POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,376,019 | +56.6% | 1,418,317 | +15.8% | 0.00% | – |
| Q2 2023 | $2,155,237 | +38.3% | 1,224,567 | +142.0% | 0.00% | – |
| Q1 2023 | $1,558,757 | +59760.1% | 506,090 | +3.0% | 0.00% | – |
| Q4 2022 | $2,604 | -99.8% | 491,472 | +8.0% | 0.00% | – |
| Q3 2022 | $1,606,000 | +137.2% | 455,052 | +73.4% | 0.00% | – |
| Q2 2022 | $677,000 | -70.0% | 262,481 | -47.8% | 0.00% | – |
| Q1 2022 | $2,253,000 | -32.5% | 503,032 | +2.5% | 0.00% | – |
| Q4 2021 | $3,340,000 | +21.6% | 490,599 | +30.2% | 0.00% | – |
| Q3 2021 | $2,746,000 | -27.2% | 376,749 | +0.1% | 0.00% | -100.0% |
| Q2 2021 | $3,772,000 | -1.9% | 376,544 | -6.5% | 0.00% | 0.0% |
| Q1 2021 | $3,846,000 | +64.7% | 402,793 | +89.2% | 0.00% | – |
| Q4 2020 | $2,335,000 | +39.4% | 212,907 | +12.7% | 0.00% | – |
| Q3 2020 | $1,675,000 | – | 188,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |